Ali Yılmaz

495 total citations
25 papers, 347 citations indexed

About

Ali Yılmaz is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ali Yılmaz has authored 25 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ali Yılmaz's work include Inflammatory Biomarkers in Disease Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Ali Yılmaz is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Ali Yılmaz collaborates with scholars based in Türkiye. Ali Yılmaz's co-authors include Mehmet Bilici, Salim Başol Tekin, Cem Mirili, Güzin Demirağ, Semra Paydaş, Nalan Akgül Babacan, Enver Sancakdar, Köksal Deveci, Turgut Kaçan and Mehmet Şeker and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Colorectal Disease and Clinical Rheumatology.

In The Last Decade

Ali Yılmaz

21 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Yılmaz Türkiye 10 243 77 64 63 36 25 347
Cem Mirili Türkiye 9 212 0.9× 80 1.0× 45 0.7× 35 0.6× 27 0.8× 21 293
Fahriye Tuğba Köş Türkiye 10 182 0.7× 77 1.0× 50 0.8× 28 0.4× 43 1.2× 40 274
Bahriye Payzın Türkiye 9 268 1.1× 82 1.1× 33 0.5× 66 1.0× 19 0.5× 33 450
Xuefeng Ni China 10 232 1.0× 73 0.9× 104 1.6× 50 0.8× 112 3.1× 21 452
Masashi Tsunematsu Japan 10 162 0.7× 64 0.8× 106 1.7× 71 1.1× 34 0.9× 68 293
Qilong Yi United States 11 85 0.3× 77 1.0× 91 1.4× 31 0.5× 78 2.2× 17 421
Yuki Imaoka Japan 10 167 0.7× 103 1.3× 178 2.8× 52 0.8× 50 1.4× 87 415
Kiyoshi Kubochi Japan 10 212 0.9× 106 1.4× 202 3.2× 49 0.8× 56 1.6× 30 433

Countries citing papers authored by Ali Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Ali Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Yılmaz more than expected).

Fields of papers citing papers by Ali Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Yılmaz. The network helps show where Ali Yılmaz may publish in the future.

Co-authorship network of co-authors of Ali Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Yılmaz. A scholar is included among the top collaborators of Ali Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Yılmaz. Ali Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karaçin, Cengiz, Zuhat Urakçı, Ali Yılmaz, et al.. (2024). Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer. Future Oncology. 20(4). 207–214.
2.
Kızılay, Gülnür, et al.. (2023). Effects of electroacupuncture at ST36 and BL20 on the diabetic rat testis. Acupuncture in Medicine. 41(5). 297–306. 1 indexed citations
3.
Yılmaz, Ali, et al.. (2023). The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer. Future Oncology. 19(4). 315–325. 5 indexed citations
4.
Demirağ, Güzin, et al.. (2021). Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy. Journal of College of Physicians And Surgeons Pakistan. 31(5). 546–552. 5 indexed citations
5.
Yılmaz, Ali, et al.. (2021). A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio.. PubMed. 31(6). 566–574. 4 indexed citations
6.
Yılmaz, Ali, et al.. (2021). A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio. Melanoma Research. 31(6). 566–574. 8 indexed citations
7.
Yılmaz, Ali, et al.. (2021). Prognostic Significance of Hemoglobin-To-Red Cell Distribution Width Ratio in Patients with Metastatic Renal Cancer. Future Oncology. 17(29). 3853–3864. 28 indexed citations
8.
Demirağ, Güzin, et al.. (2021). Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib. Journal of Pharmacy & Pharmaceutical Sciences. 24. 148–152. 1 indexed citations
9.
Yılmaz, Ali, et al.. (2021). The Importance of the Glucose-To-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Future Oncology. 17(33). 4545–4559. 13 indexed citations
10.
11.
Yılmaz, Ali, et al.. (2020). Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer. Acta Oncologica Turcica. 53(3). 402–409.
12.
Yılmaz, Ali, Cem Mirili, Mehmet Bilici, & Salim Başol Tekin. (2020). Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia. Journal of Oncology Pharmacy Practice. 26(7). 1791–1794. 12 indexed citations
13.
Yılmaz, Ali, Cem Mirili, Salim Başol Tekin, & Mehmet Bilici. (2019). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. Irish Journal of Medical Science (1971 -). 189(1). 91–102. 30 indexed citations
14.
Mirili, Cem, et al.. (2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. International Journal of Clinical Oncology. 24(10). 1301–1310. 80 indexed citations
15.
Yılmaz, Ali, Cem Mirili, Mehmet Bilici, & Salim Başol Tekin. (2019). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. International Journal of Colorectal Disease. 35(2). 351–353. 8 indexed citations
16.
Mirili, Cem, et al.. (2019). Systemic Immune-Inflammation Index Predicting Survival Outcome in Patients with Classical Hodgkin Lymphoma. Biomarkers in Medicine. 13(18). 1565–1575. 36 indexed citations
17.
Mirili, Cem, Ali Yılmaz, Mehmet Bilici, & Salim Başol Tekin. (2019). Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey. SHILAP Revista de lepidopterología. 46(4). 857–865. 1 indexed citations
18.
Candan, Ferhan, et al.. (2017). Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis. Clinical Rheumatology. 36(11). 2589–2594. 5 indexed citations
19.
Şeker, Mehmet, Köksal Deveci, Enver Sancakdar, et al.. (2015). Predictive Role of Neutrophil Gelatinase-Associated Lipocalin in Early Diagnosis of Platin-Induced Renal Injury. Asian Pacific Journal of Cancer Prevention. 16(2). 407–410. 12 indexed citations
20.
Yönem, Özlem, et al.. (2009). Duodenal stromal tumor: a rare and overlooked cause of massive gastrointestinal bleeding.. PubMed. 20(2). 150–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cem Mirili Breakdown of academic impact, for papers by Fahriye Tuğba Köş Breakdown of academic impact, for papers by Bahriye Payzın Breakdown of academic impact, for papers by Xuefeng Ni Breakdown of academic impact, for papers by Masashi Tsunematsu Breakdown of academic impact, for papers by Qilong Yi Breakdown of academic impact, for papers by Yuki Imaoka Breakdown of academic impact, for papers by Kiyoshi Kubochi
Rankless by CCL
2026